AdhexPharma

🎄As the year draws to a close, we'd like to wish you all the very best for the coming festive season. We want to take a moment to express our gratitude for your trust and partnership throughout the year. Your continued support has been instrumental to our success, and we are truly honored to serve you. May the new year bring you prosperity, health, and many new opportunities. Thank you for allowing us to be part of your journey. We look forward to working together in 2025 and beyond 🎀 Warm regards, The AdhexPharma Teams

12 major global events on 2 continents 🌍 This year, we had the pleasure of participating in 12 major events across Europe and the United States. These unique occasions allowed us to: ✅ Strengthen our relationships with loyal clients and partners, ✅ Showcase our innovative solutions to new audiences, ✅ Explore inspiring ideas to keep innovating and addressing the needs of our ecosystem. Each of these events was a fantastic opportunity for collaboration and learning, reaffirming our commitment to being at the heart of industry conversations. 📅The upcoming year promises to be even more ambitious: we plan to attend 14 international events, with an exciting new highlight – 2 of them will take place in Japan. It’s a wonderful opportunity to broaden our horizons and share our projects with an even larger community. In the name of AdhexPharma and Labtec, thank you to everyone who helped make 2024 unforgettable. We look forward to continuing this incredible journey together in 2025! 🚀 #Innovation #Partnerships #Growth #Global #Events #Connections #Pharma #Healthcare

Why oral films are the future of medical treatment delivery ? Oral films are set to be more commercialized and use for patients treatments because they offer many advantages. Let's take the example of the dispersion of an active ingredient from an oral film via the buccal mucosa compared to administration through the gastrointestinal (GI) route : - Rapid and Direct Absorption - Faster Onset of Action - Reduction in Gastrointestinal Side Effects - Ease of Administration - More Precise Dose Control Read more details here 👉 https://lnkd.in/efJswJ2p #OralFilm #Innovation #Healthcare #Pharma #Article

AdhexPharma ranked 6th in the Europe’s Long-Term Growth Champions Pharmaceuticals & Cosmetics category, by the Financial Times and Statista. Since its founding in 2008, AdhexPharma has steadily built a reputation for quality and innovation. We currently manufacture eight approved products, including oral films and transdermal patches, with an impressive annual output of more than 100 million units per year. Our 25% annual growth rate over the past decade reflects our commitment to meeting the evolving needs of the healthcare sector. 🔗 Read the full article here 👇 https://lnkd.in/ezpu-qHD

At AdhexPharma, we're proud to introduce Mucofilm®, a breakthrough in precision drug delivery. This advanced mucoadhesive film technology offers an innovative solution for the delivery of your Active Pharmaceutical Ingredient. What makes Mucofilm® a cutting-edge technology? ✔️ Precise and efficient delivery: Designed for immediate, directional, or controlled release of APIs. ✔️ Discreet and user-friendly: Ultra-lightweight and virtually undetectable for maximum patient comfort. ✔️ Customizable: Tailored dissolution rates—from instantaneous to prolonged action—depending on therapeutic needs. ✔️ Enhanced bioavailability: Facilitates transmucosal delivery to bypass the first-pass effect, ensuring systemic treatment is highly effective. ✔️ Versatile applications: From local treatment of oral inflammations to systemic therapies, Mucofilm® adapts to your requirements. Whether your API needs to act locally in the oral cavity or systemically across the body, Mucofilm® is the perfect partner to deliver unparalleled results. #Healthcare #Innovation #Medicaldevice #Pharma #Mucoadhesivefilm #Oralfilm

📢 Paul Mourier, Préfet de la Région Bourgogne-Franche-Comté et du Département de la Côte-d'Or était présent sur le site d'AdhexPharma lundi 18 novembre afin de lancer la 13ème édition de la Semaine de l'Industrie en Bourgogne-Franche-Comté. Il a également annoncé la subvention accordée à AdhexPharma dans le cadre de l'AAP #France2030 'Industrialisation et capacités Santé" d'un montant de 4.130M€ pour un investissement total de 25,1M€. Roland de la Brosse, Bruno Loiseau ainsi que Maxime Heraud ont pu présenter à Monsieur le Préfet ainsi qu'aux autres personnalités représentant la région, la métropole de Dijon, l'Etat et ses services économiques, la stratégie de développement d'AdhexPharma. Ils ont notamment évoqué la construction en cours du nouveau bâtiment qui verra le jour fin 2025. S'en est suivi une visite sur le chantier de construction, puis en salles blanches afin de comprendre les processus de fabrication de nos patchs transdermiques et films oraux. Nous remercions chaleureusement Monsieur le Préfet ainsi que tous les autres participants présents lors de cette visite. Ville de Chenôve Géraldine Leveau Secrétariat général pour l'investissement Anne Coste de Champeron Domitille Legrand Françoise Tenenbaum Eric Oternaud Thierry Falconnet Antoine Jarrige Cedric Duboudin Pascal Auzière Jean-claude Lagrange Dijon métropole ------------------------------------------------------------------------------------ Paul Mourier, Prefect of the Bourgogne-Franche-Comté Region and the Côte-d'Or Department, was on hand at the AdhexPharma site on Monday November 18 to launch the 13th edition of Industry Week in Bourgogne-Franche-Comté.  He also announced the grant awarded to AdhexPharma as part of the AAP #France2030 'Industrialisation et capacités Santé' in the amount of €4.130M for a total investment of €25.1M. Roland de la Brosse, Bruno Loiseau and Maxime Heraud presented AdhexPharma's development strategy to the Prefect and other personalities representing the region, the Dijon metropolitan area, the French government and its economic services. In particular, they discussed the construction of the new building currently underway, which will be completed by the end of 2025. This was followed by a visit to the construction site, and then to the clean rooms to understand the manufacturing processes for our transdermal patches and oral films. We would like to extend our warmest thanks to Mr. Préfet and all the other participants in this visit. #Dijon #SEDI2024 #Industrie #Pharma #Développement #France2030 #Chenôve

🎥 Retour en images sur une visite exceptionnelle pour AdhexPharma ! Nous avons eu l'honneur d'accueillir le Préfet de la région M. Paul Mourier sur notre site, une visite riche en échanges et en annonces qui marquent un tournant dans notre développement. 🔍 Au programme de cette journée : Une visite du chantier de notre nouveau bâtiment en cours de construction, symbolisant notre ambition de croissance. Une découverte immersive de nos salles de production, reflet de notre expertise et de notre savoir-faire industriel. Le lancement officiel de la 13ᵉ Semaine de l'Industrie, un événement national clé pour valoriser le rôle crucial du secteur industriel dans notre économie et notre région. ✨ Moment fort : le Préfet a annoncé un financement de 4,13 millions d'euros dans le cadre de l'AAP France 2030 'Industrialisation et capacités Santé", destiné à soutenir nos projets d'innovation et notre développement dans la région. #CôtedOr #Dijon #Chenôve #France #Industrialisation #Pharmaceutique #SemainedelIndustrie

Nous sommes ravis de vous informer de l’avancement d’un projet majeur pour AdhexPharma : La construction de notre nouveau bâtiment de 8000 m² est en bonne voie ! Ce projet stratégique, aligné avec notre ambition de croissance, incarne notre volonté de renforcer notre position en tant qu'expert dans la fabrication de films oraux et de patchs. Ce nouveau bâtiment aura de nombreuses fonctions : production, stockage, laboratoires QC et R&D. Il y aura également des bureaux administratifs aux étages supérieurs. ✅ Le terrassement de la surface, la réalisation du bassin de rétention des eaux d'incendie ainsi que l'installation de pieux en profondeur pour assurer la répartition des charges du bâtiment ont été réalisée. 🔜 Les premiers poteaux ainsi que les premiers murs béton coupe-feu ont été mis en place ces derniers jours. 🚀 Restez connectés pour suivre les prochaines étapes ! Groupe Guiton - STUDIO MUSTARD ARCHITECTURE - croqüs #Innovation #DéveloppementDurable #AdhexPharma #Croissance #Dijon

Last Week to read Mathieu Reuther's scientific article for free 📰 📢 The article, titled "Development of a new method for analyzing the behavior of rapidly dissolving films in contact with liquids", explores the dissolution of oral films in different liquids in order to determine their pearmability and disintegration time. Check out the full article for free here : https://lnkd.in/e3dUXAAE #PharmaceuticalScience #ResearchInnovation #DrugDelivery #AdhexPharma #ScientificBreakthroughs #OralFilms #Science

We are honored to share that we have been ranked by The Financial Times and STATISTA as the 171st of Europe’s Long-Term Growth Champions! This recognition highlights our sustained sales growth in a time when many are facing economic challenges across the continent. Our team's dedication and resilience have been key to achieving this distinction, and we're excited to continue building on this momentum. Read the full article here 🔗 : https://lnkd.in/dHHF37Qj